Table 3.
Retinal layer thickness* (μm, mean±SE) |
Number of eyes | MPOD-CAREDS baseline, 0.5° (optical density units) | β±SE (1−SD increase) |
P-trend | |||
Quartile 1 (0.00–0.23) |
Quartile 2 (0.23–0.38) |
Quartile 3 (0.38–0.51) |
Quartile 4 (0.51–1.00) |
||||
Peripapillary RNFL | |||||||
Average | 631 | 93.9±1.0 | 93.6±1.0 | 92.8±1.0 | 93.2±0.9 | 0.3±0.5 | 0.53 |
Inferior | 631 | 120.9±1.4 | 121.2±1.5 | 120.1±1.6 | 121.1±1.7 | 0.2±0.7 | 0.77 |
Superior | 631 | 111.6±1.5 | 110.9±1.4 | 109.8±1.4 | 110.9±1.4 | 0.2±0.8 | 0.80 |
Nasal | 631 | 72.3±1.2 | 72.3±1.2 | 70.7±1.2 | 71.2±1.1 | 0.7±0.6 | 0.26 |
Temporal | 631 | 71.4±1.3 | 70.3±1.3 | 70.8±1.2 | 69.7±1.2 | 0.4±0.6 | 0.50 |
Macular RNFL | |||||||
Central | 668 | 13.2±0.3 | 12.9±0.2 | 13.1±0.2 | 13.7±0.2 | 0.2±0.1 | 0.13 |
Inner | 668 | 23.9±0.3 | 23.5±0.3 | 23.5±0.2 | 23.6±0.2 | 0.1±0.1 | 0.53 |
Outer | 666 | 40.1±0.6 | 39.1±0.5 | 39.7±0.5 | 39.6±0.5 | 0.0±0.3 | 0.88 |
Macular GCL | |||||||
Central | 667 | 15.7±0.5 | 15.6±0.5 | 16.2±0.3 | 17.2±0.4 | 0.5±0.2 | 0.01 |
Inner | 668 | 46.0±0.5 | 46.0±0.5 | 46.3±0.5 | 46.6±0.4 | 0.3±0.2 | 0.26 |
Outer | 665 | 30.2±0.3 | 30.1±0.3 | 30.5±0.3 | 30.3±0.3 | 0.1±0.1 | 0.38 |
Macular IPL | |||||||
Central | 669 | 20.9±0.4 | 20.8±0.3 | 21.4±0.3 | 22.4±0.3 | 0.6±0.2 | <0.001 |
Inner | 669 | 38.0±0.3 | 38.0±0.3 | 38.1±0.3 | 38.4±0.2 | 0.2±0.1 | 0.23 |
Outer | 668 | 25.4±0.2 | 25.5±0.2 | 25.6±0.2 | 25.7±0.2 | 0.1±0.1 | 0.15 |
Macular GCC | |||||||
Central | 656 | 49.2±1.0 | 48.9±1.0 | 50.6±0.8 | 53.1±0.8 | 1.3±0.4 | 0.003 |
Inner | 657 | 107.6±0.9 | 107.4±1.0 | 107.8±1.0 | 108.5±0.7 | 0.4±0.4 | 0.35 |
Outer | 655 | 95.5±0.8 | 94.7±0.9 | 95.6±1.0 | 95.6±0.8 | 0.3±0.4 | 0.50 |
*Adjusted for age and axial length.
CAREDS, Carotenoids in Age-Related Eye Disease Study; GCC, ganglion cell complex; GCL, ganglion cell layer; IPL, inner plexiform layer; MPOD, macular pigment optical density; POAG, primary open-angle glaucoma; RNFL, retinal nerve fibre layer.